Related Experiment Video

Updated: Jul 6, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

Platensimycin: a promising antimicrobial targeting fatty acid synthesis

D T Manallack1, I T Crosby, Y Khakham

  • 1Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia. David.Manallack@vcp.monash.edu.au

Current Medicinal Chemistry
|March 14, 2008
PubMed

Insights

Platensimycin, a novel antibiotic, effectively targets Gram-positive bacteria by inhibiting fatty acid synthesis. Its discovery highlights the power of natural product screening and RNA gene-silencing techniques in identifying new antimicrobial agents.

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Platensimycin is a recently discovered antibiotic with potent activity against Gram-positive bacteria, including resistant strains.
  • Its discovery utilized RNA gene-silencing and natural product screening, bypassing conventional methods.
  • The compound targets beta-ketoacyl synthases I/II (FabF/B), crucial for bacterial fatty acid biosynthesis.

Purpose of the Study:

  • To review the origins and discovery of platensimycin.
  • To elucidate its mechanism of action, focusing on the inhibition of FabF/B enzymes.
  • To discuss synthetic strategies and potential future directions for platensimycin analogs.

Main Methods:

  • Discovery through RNA gene-silencing and natural product screening.
  • Investigation of antibacterial activity against Gram-positive organisms.
  • Analysis of the mechanism of action targeting beta-ketoacyl synthases I/II (FabF/B).

Main Results:

  • Platensimycin exhibits potent activity against a range of Gram-positive bacteria, including resistant strains.
  • The antibiotic functions by inhibiting key enzymes (FabF/B) in bacterial fatty acid synthesis.
  • Synthetic efforts have led to the creation of active platensimycin analogs.

Conclusions:

  • Platensimycin represents a significant advancement in antibiotic discovery due to its novel mechanism and potent activity.
  • Further exploration of synthetic analogs is warranted, despite limited patenting by the discoverers.
  • The study of platensimycin offers insights into bacterial cell membrane biosynthesis and potential new therapeutic strategies.

More Related Videos

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids11:59

Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids

Published on: May 15, 2019

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...